Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-40,000
Closed -$780K 38
2023
Q3
$780K Sell
40,000
-25,000
-38% -$447K 0.66% 30
2023
Q2
$1.33M Buy
65,000
+17,718
+37% +$342K 1.15% 27
2023
Q1
$838K Buy
47,282
+9,282
+24% +$149K 0.82% 26
2022
Q4
$466K Buy
38,000
+10,886
+40% +$117K 0.44% 27
2022
Q3
$217K Buy
27,114
+4,000
+17% +$43.8K 0.24% 29
2022
Q2
$266K Buy
23,114
+3,114
+16% +$41.6K 0.29% 30
2022
Q1
$341K Buy
20,000
+14,000
+233% +$381K 0.29% 34
2021
Q4
$257K Buy
+6,000
New +$293K 0.22% 38
2021
Q3
Sell
-17,000
Closed -$778K 42
2021
Q2
$778K Buy
+17,000
New +$750K 0.65% 35

Other funds holding VEON

Clayton Partners's VEON Position: Q4 2023 in Review

Clayton Partners sold out of VEON (VEON) in Q4 2023, closing a stake of 40,000 shares — an estimated $780K sold.

Clayton Partners first reported a position in VEON in Q2 2021 and held it in 9 quarters. The position peaked at $1.33M in Q2 2023. 38 funds tracked by Wall St. Rank hold VEON as of Q4 2023.

  • Clayton Partners reported no remaining VEON position as of Q4 2023 after selling out during the quarter.
  • Clayton Partners sold 40,000 VEON shares in Q4 2023, an estimated $780K.
  • Clayton Partners first reported a position in VEON in Q2 2021 and held it in 9 quarters.
  • Clayton Partners's VEON position peaked at $1.33M in Q2 2023.
  • 38 funds tracked by Wall St. Rank held VEON as of Q4 2023.

Based on Clayton Partners's 13F filing for Q4 2023, filed 14 Feb 2024.